Achillion Pharmaceuticals, Inc. (ACHN) opening the day at $4.1. The company has seen its stock decrease in value by -62% so far this year. The stock was up close to 0.74% on light volume in last trading session and closed at $4.1 per share. After the recent gain, the stock is currently holding -62.56% below its 52 week high of $10.66 and 8.47% above its 12-month low of $3.78. The shares are down by over -48.3% in the last three months, and the RSI indicator value of 41.11 is neither bullish nor bearish, tempting investors to stay on the sidelines.
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecule drug therapies for infectious diseases and immune system disorders in the United States and internationally. Its drug candidates for treating chronic hepatitis C virus (HCV) infection comprise Odalasvir, a NS5A inhibitor, which has completed Phase IIa clinical trials; ACH-3422, a NS5B nucleotide polymerase inhibitor; and Sovaprevir, a NS3 protease inhibitor, which has completed Phase II clinical trial. The company is also developing ACH-4471, a complement factor D inhibitor that is in Phase I clinical trial to treat patients with paroxysmal nocturnal hemoglobinuria and one additional systemic ultra-rare disease; and other factor D inhibitors. It has a license and development agreement with Ora, Inc. for the development and commercialization of ACH-702, an antibacterial drug candidate that is delivered topically or locally; and license and collaboration arrangement with Janssen Pharmaceuticals Inc. to develop and commercialize antiviral drug candidates for treating HCV infection. The company was founded in 1998 and is headquartered in New Haven, Connecticut.
Cemtrex, Inc. (CETX) managed to rebound with the stock climbing 15.65% or $0.95 to close the day at $7.02 on light trading volume of 1.74M shares, compared to its three month average trading volume of 314.65K. The Farmingdale New York 11735 based company has been outperforming the industrial equipment & components group over the past 52 weeks, with the stock gaining 191.29%, compared to the industry which has advanced 35.71% over the same period. With RSI of 72.76, the stock should still continue to rise and get closer to its one year target estimate of $5, making it a hold for now.
Cemtrex, Inc. provides electronic manufacturing services of custom engineered advanced electronics system assemblies, emission monitors and instruments for industrial processes, and environmental control and air filtration systems for industries and utilities. It designs, develops, and manufactures various interconnects and cable assemblies; and provides engineering services, including new product introductions and prototyping, related testing equipment, and product redesigns. The company also manufactures, sells, and services monitoring instruments, software, and systems for measurement of emissions of Greenhouse gases, hazardous gases, particulate, and other regulated pollutants used in emissions trading, as well as for industrial processes; and markets monitoring and analysis equipment for gas and liquid measurement for various downstream oil and gas applications, as well as industrial process applications. In addition, it offers air filtration and environmental control equipment to industries, such as chemical, cement, steel, food, construction, mining, and petrochemicals; instruments for emissions monitoring, process analysis, and controls for industrial applications; and laser opacity monitor that is used to determine opacity or dust concentration in stack gases. Further, the company provides direct-extractive and dilution-extractive continuous emissions monitoring solutions equipment and systems for use with utilities, industrial boilers, FGD systems, SCR-NOx control, furnaces, gas turbines, process heaters, and incinerators; and crude oil and natural gas analyzers. It serves primarily automotive, medical, industrial automation, refining, power, chemical, mining, and metallurgical processing industries. The company was formerly known as Diversified American Holding, Inc. and changed its name to Cemtrex, Inc. in December 2004. Cemtrex, Inc. was incorporated in 1998 and is based in Farmingdale, New York.
Kohl’s Corporation (KSS) gained $0.25 to close the day at a new closing price of $50.06, a 0.5% increase in value from its previous closing price that moved the stock 52.88% above its 52 week low of $33.87. A total of 1.74M shares exchanged hands during the day compared with its three month average trading volume of 3.9M. The stock, which fluctuated between $49.54 and $50.3 during the day, currently situated -16.11% below its 52 week high. The stock is down by -6.69% in the past one month and up by 18.03% over the past three months. With a one year target estimate of $51.95 and RSI of 43.43, the stock still has upside potential, making it a hold for now.
Kohl’s Corporation operates department stores in the United States. It offers private label, exclusive, and national brand apparel, footwear, accessories, beauty, and home products to children, men, and women customers. The company also sells its products online through Website Kohls.com. As of January 30, 2016, it operated 1,164 department stores in 49 states. Kohl’s Corporation was founded in 1962 and is headquartered in Menomonee Falls, Wisconsin.